Meditech Spine’s Talos devices receive FDA clearance for use with allograft bone graft: 3 notes

Meditech Spine’s Talos interbody devices have received FDA clearance for use with allograft comprised of cancellous or corticocancellous bone graft.

Advertisement

Here are three notes:

 

1. Meditech’s interbody cervical and lumbar devices are indicated for use with autograft or allograft.

 

2. These devices include the Talos-P, Talos-T, Talos-A, Talos-L and both the Talos-C and Talos-C (HA) interbody implants.

 

3. Meditech Spine is a spinal implant company. It obtained its first FDA clearance in 2009.

 

More articles on devices:
Minimally invasive surgical instrument market forecast: 3 takeaways
joimax launches EndoLIF On-Cage, iLESSYS Delta interlaminar systems
Life Spine releases devices for expandable lateral interbody fusions

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.